SSG
ARTC

Summit Securities Group’s ARTHROCARE CORP ARTC Stock Holding History

Summit Securities Group’s Portfolio ARTC Stock Details ARTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-800
Closed -$28K – 686
2013
Q2 		$28K Buy
+800
New +$27.5K 0.01% 224

Other funds holding ARTC

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Summit Securities Group's ARTC Position: Q3 2013 in Review

Summit Securities Group sold out of ARTHROCARE CORP (ARTC) in Q3 2013, closing a stake of 800 shares — an estimated $28K sold.

Summit Securities Group first reported a position in ARTC in Q2 2013 and held it in 1 quarter. The position peaked at $28K in Q2 2013. 118 funds tracked by Wall St. Rank hold ARTC as of Q3 2013.

  • Summit Securities Group reported no remaining ARTHROCARE CORP position as of Q3 2013 after selling out during the quarter.
  • Summit Securities Group sold 800 ARTHROCARE CORP shares in Q3 2013, an estimated $28K.
  • Summit Securities Group first reported a position in ARTHROCARE CORP in Q2 2013 and held it in 1 quarter.
  • Summit Securities Group's ARTHROCARE CORP position peaked at $28K in Q2 2013.
  • 118 funds tracked by Wall St. Rank held ARTHROCARE CORP as of Q3 2013.

Based on Summit Securities Group's 13F filing for Q3 2013, filed 1 Nov 2013.